Celiac disease affects roughly 1% of the general population worldwide, making it one of the more common autoimmune conditions but one that often flies under the radar. In the United States, the prevalence sits at about 0.7% of the population, or an estimated 1.76 million people. That 1-in-100 figure holds fairly consistent across Europe, North America, and other Western countries, though the numbers shift depending on who you are, where you live, and whether anyone in your family has it.
How Common It Actually Is
A prevalence of about 1% means celiac disease is far from rare in the medical sense. For comparison, type 1 diabetes affects roughly 0.5% of the population. What makes celiac disease seem rarer than it is comes down to diagnosis: a large Norwegian study of over 56,000 adults found a total biopsy-confirmed prevalence of 1.5%, with a striking ratio of 1.2 newly diagnosed cases for every 1 previously known case. In other words, for every person walking around with a celiac diagnosis, at least one more has the disease without knowing it.
A German study screening nearly 13,000 children and adolescents found a similar pattern. Only 0.07% had a reported history of celiac disease, but when researchers tested their blood for celiac-specific antibodies, the true prevalence jumped to 0.9%. That tenfold gap between diagnosed and actual cases is a consistent finding across countries.
It’s Becoming More Common
Celiac disease is not holding steady. A systematic review pooling data from multiple countries found that the incidence has been rising by about 7.5% per year over the past several decades. Some of that increase reflects better awareness and testing, but studies using stored blood samples from past decades confirm that the biological prevalence itself is climbing, not just the diagnosis rate. The reasons aren’t fully understood, but changes in infant feeding practices, gut bacteria, and environmental exposures are all under investigation.
Who Gets It More Often
Race and ethnicity play a significant role in celiac disease risk, at least in the United States. Non-Hispanic whites have the highest prevalence at about 1.08%. Rates are substantially lower in Mexican Americans (0.23%), other Hispanic groups (0.38%), and non-Hispanic Black Americans (0.22%). About 10% of celiac patients identified in U.S. screening studies have a race or ethnicity other than non-Hispanic white. These differences largely track with the frequency of specific genetic markers that are more common in people of European descent.
If you have type 1 diabetes, your risk jumps considerably. Studies report celiac disease in anywhere from 1.7% to 16% of people with type 1 diabetes, with most estimates landing around 5 to 8%. Autoimmune thyroid disease also clusters with celiac, appearing in 4 to 14% of celiac patients. These overlapping conditions share genetic roots, so having one autoimmune disease raises the odds of developing another.
The Family Factor
Celiac disease runs strongly in families. Up to 20% of first-degree relatives (parents, siblings, children) of someone with celiac disease are affected themselves, and concordance rates in identical twins reach 75 to 80%. A large meta-analysis put the overall figure at about 1 in 14 first-degree relatives having biopsy-confirmed celiac disease, but the risk isn’t evenly distributed. Daughters of celiac patients have the highest rate at roughly 1 in 4. Sisters come next at about 1 in 7, followed by brothers at 1 in 11, sons at 1 in 16, and parents at approximately 1 in 20.
These numbers are dramatically higher than the general population rate of 1 in 100. If you have a close relative with celiac disease, screening is worth considering even if you feel fine, since the disease can cause damage to the small intestine without producing obvious symptoms.
Genetics vs. Developing the Disease
Celiac disease requires specific genetic markers to develop. Between 30 and 40% of the general population carries these genes, but only about 3% of carriers ever develop the disease. That means the genetic predisposition is common, but something else, likely an environmental trigger, has to flip the switch. Having the genes is necessary but far from sufficient. Conversely, if you’ve been tested and don’t carry these markers, your chance of developing celiac disease is essentially zero.
The Diagnosis Gap
One of the most striking things about celiac disease is how long it takes to identify. Studies have documented an average delay of nearly 10 years between the first symptoms and a formal diagnosis, with some research placing the figure as high as 11 to 13 years. The median is closer to 4 years, meaning half of patients wait at least that long while the other half wait much longer. This delay has real consequences: longer time to diagnosis is associated with lower quality of life, and the intestinal damage continues accumulating the entire time.
The gap exists partly because celiac symptoms overlap with many other conditions. Bloating, fatigue, and digestive discomfort are easy to attribute to irritable bowel syndrome or stress. Some people have no digestive symptoms at all and instead present with anemia, joint pain, skin rashes, or neurological issues. This variability makes celiac disease one of the most underdiagnosed conditions in medicine, despite being far from rare by any standard measure.